- Tytuł:
- A randomized phase II/III study of 'novel therapeutics' versus azacitidine in newly diagnosed patients with acute myeloid leukemia (AML), high-risk myelodysplastic syndrome (MDS), or chronic myelomonocytic leukemia (CMML), age 60 or older: a report of the comparison of azacitidine and nivolumab to azacitidine: SWOG S1612.
- Autorzy:
- Źródło:
- Leukemia & lymphoma [Leuk Lymphoma] 2023 Feb; Vol. 64 (2), pp. 473-477. Date of Electronic Publication: 2022 Dec 14.
- Typ publikacji:
- Clinical Trial, Phase II; Randomized Controlled Trial; Journal Article; Research Support, N.I.H., Extramural
- MeSH Terms:
-
Leukemia, Myelomonocytic, Chronic*/diagnosis
Leukemia, Myelomonocytic, Chronic*/drug therapy
Myelodysplastic Syndromes*/diagnosis
Myelodysplastic Syndromes*/drug therapy
Leukemia, Myeloid, Acute*/diagnosis
Leukemia, Myeloid, Acute*/drug therapy
Leukemia, Myeloid, Acute*/chemically induced
Humans ; Middle Aged ; Azacitidine/adverse effects ; Nivolumab/therapeutic use
Czasopismo naukowe